Camber Pharmaceuticals recently added Indomethacin Suppositories [IN-doe-METH-a-sin] to its portfolio. Indomethacin Suppositories are a nonsteroidal anti-inflammatory drug […]
Camber Launches Indomethacin Suppositories
Currently browsing: News
Camber Launches Voriconazole for Injection
Camber is excited to welcome Voriconazole for Injection [vor-i-KON-a-zole] to its expanding portfolio. Voriconazole for Injection is […]
Camber Launches Magnesium Sulfate Injection
Camber, a leader in generic drug approvals and launches, is proud to add Magnesium Sulfate […]
NACDS TSE 2025 Recap
The NACDS Total Store Expo continues to be a flagship event for Camber Pharmaceuticals, […]
Susan Stipic-Ryan Joins Camber’s Sales Team
Camber Pharmaceuticals is pleased to announce that Susan Stipic-Ryan joined the Rx Sales Team in […]
Camber Launches Bexarotene Capsules
Camber Pharmaceuticals, a leader in generic drug approvals and launches, is proud to add Bexarotene […]
Camber Pharmaceuticals Appoints Scott Hettenhausen as Vice President of Rx Sales
Camber Pharmaceuticals is pleased to announce the appointment of Scott Hettenhausen as Vice President of […]
Camber Launches Spironolactone Oral Suspension
Piscataway, NJ, September 3, 2025 – Camber Pharmaceuticals is excited to welcome Spironolactone Oral Suspension […]
Camber Launches Metformin Hydrochloride Oral Solution
Camber Pharmaceuticals, a leader in generic drug approvals and launches, is proud to add Metformin […]
Camber Launches Colchicine Capsules
Click to listen to this article. Piscataway, NJ, July 29, 2025 – As a leader […]